All publications
61-90 elements, in total: 175
Huleatt, P B; Khoo, M L; Chua, Y Y; Tan, T W; Liew, R S; Balogh, B; Deme, R; Goloncser, F; Magyar, K; Sheela, D P; Ho, H K; Sperlagh, B; Matyus, P; Chai, C L L
(2015)
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s disease
JOURNAL OF MEDICINAL CHEMISTRY 1520-4804 58: 1400-1419
Ficker, C; Rozmer, K; Kató, E; Andó, RD; Schumann, L; Krügel, U; Franke, H; Sperlágh, B; Riedel, T; Illes, P
(2014)
Astrocyte-neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor-mediated release of glutamate and reactive oxygen species.
GLIA 1098-1136 62: 1671-1686
Horvath, G; Goloncser, F; Csolle, C; Kiraly, K; Ando, RD; Baranyi, M; Kovanyi, B; Mate, Z; Hoffmann, K; Algaier, I; Baqi, Y; Muller, CE; Von Kugelgen, I; Sperlagh, B
(2014)
Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.
NEUROBIOLOGY OF DISEASE 1095-953X 70: 162-178
Goloncser, F; Sperlagh, B
(2014)
Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine.
JOURNAL OF HEADACHE AND PAIN 1129-2377 15:
Sperlagh, B; Illes, P
(2014)
P2X7 receptor: an emerging target in central nervous system diseases.
TRENDS IN PHARMACOLOGICAL SCIENCES 35: 537-547
Csolle, C; Ando, RD; Kittel, A; Goloncser, F; Baranyi, M; Soproni, K; Zelena, D; Haller, J; Nemeth, T; Mocsai, A; Sperlagh, B
(2013)
The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 1469-5111 16: 213-233
Andó, Rómeó; Sperlágh, Beáta
(2013)
The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain
BRAIN RESEARCH BULLETIN 1873-2747 93: 80-85
Csolle, C; Baranyi, M; Zsilla, G; Kittel, A; Goloncser, F; Illes, P; Papp, E; Vizi, ES; Sperlagh, B
(2013)
Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors.
PLOS ONE 1932-6203 8:
Mátyus, P; Huleatt, P; Chai, CLL; Sperlágh, B; Ling, KM; Magyar, K; Papp-Behr, Á; Deme, R; Túrós, G; Gyires, K
(2013)
Novel (hetero)aryl propargylamines for the treatment of neurodegenerative disorders.
Tautenhahn, M; Leichsenring, A; Servettini, I; Pesic, M; Sperlagh, B; Norenberg, W; Illes, P
(2012)
Purinergic modulation of the excitatory synaptic input onto rat striatal neurons
NEUROPHARMACOLOGY 1873-7064 62: 1756-1766
Ando, RD; Biro, J; Csolle, C; Ledent, C; Sperlagh, B
(2012)
The inhibitory action of exo- and endocannabinoids on [(3)H]GABA release are mediated by both CB(1) and CB(2) receptors in the mouse hippocampus
NEUROCHEMISTRY INTERNATIONAL 1872-9754 60: 145-152
Richter, H; Teixeira, FM; Ferreira, SG; Kittel, A; Kofalvi, A; Sperlagh, B
(2012)
Presynaptic alpha(2)-adrenoceptors control the inhibitory action of presynaptic CB(1) cannabinoid receptors on prefrontocortical norepinephrine release in the rat
NEUROPHARMACOLOGY 1873-7064 63: 784-797
Heinrich, A; Ando, R; Turi, G; Rozsa, B; Sperlagh, B
(2012)
K(+) depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study
BRITISH JOURNAL OF PHARMACOLOGY 1476-5381 167: 1003-1020
Khansari, PS; Sperlagh, B
(2012)
Inflammation in neurological and psychiatric diseases
INFLAMMOPHARMACOLOGY 1568-5608 20: 103-107
Dunkel, P; Chai, CL; Sperlágh, B; Huleatt, PB; Mátyus, P
(2012)
Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
EXPERT OPINION ON INVESTIGATIONAL DRUGS 21: 1267-1308
Kecskeméti, Valéria; Sperlágh, Beáta
(2012)
50 éves a Magyar Kísérletes és Klinikai Farmakológiai Társaság
Sperlagh, B; Csolle, C; Ando, RD; Goloncser, F; Kittel, A; Baranyi, M
(2012)
The role of purinergic signaling in depressive disorders.
NEUROPSYCHOPHARMACOLOGIA HUNGARICA 14: 231-238
Horváth, B; Iring, A; Benyó, B; Hermán, P; Lenzsér, G; Lacza, Zs; Sándor, P; Benyó, Z
(2012)
Low frequency pial arterial vasomotion and cerebrocortical blood flow oscillations in rodents
266-266
Sperlagh, B; Vizi, ES
(2011)
The Role of Extracellular Adenosine in Chemical Neurotransmission in the Hippocampus and Basal Ganglia: Pharmacological and Clinical Aspects.
CURRENT TOPICS IN MEDICINAL CHEMISTRY 1873-4294 11: 1034-1046
Sperlágh, B; Vizi, ES; Tímár, J; Kiss, J; Zelles, T
(2011)
Bevezetés a pszichotrop szerek farmakológiájába
347-363
Hracsko, Z; Baranyi, M; Csolle, C; Goloncser, F; Madarasz, E; Kittel, A; Sperlagh, B
(2011)
Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease
MOLECULAR NEURODEGENERATION 6:
Ceruti, S; Colombo, L; Magni, G; Vigano, F; Boccazzi, M; Deli, MA; Sperlagh, B; Abbracchio, MP; Kittel, A
(2011)
Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier
NEUROCHEMISTRY INTERNATIONAL 1872-9754 59: 259-271
Csolle, C; Sperlagh, B
(2011)
Endocannabinergic modulation of interleukin-1beta in mouse hippocampus under basal conditions and after in vivo systemic lipopolysaccharide stimulation
NEUROIMMUNOMODULATION 1423-0216 18: 226-231
Milusheva, E; Baranyi, M; Kormos, E; Hracsko, Z; Sylvester, Vizi E; Sperlagh, B
(2010)
The effect of antiparkinsonian drugs on oxidative stress induced pathological [3h]dopamine efflux after in vitro rotenone exposure in rat striatal slices
NEUROPHARMACOLOGY 1873-7064 58: 816-825
Ando, RD; Mehesz, B; Gyires, K; Illes, P; Sperlagh, B
(2010)
A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.
BRITISH JOURNAL OF PHARMACOLOGY 1476-5381 159: 1106-1117
Csolle, C; Sperlagh, B
(2010)
Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors
JOURNAL OF NEUROIMMUNOLOGY 1872-8421 219: 38-46
Sperlagh, B; Windisch, K; Ando, RD; Sylvester, Vizi E
(2009)
Neurochemical evidence that stimulation of cb1 cannabinoid receptors on gabaergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens
NEUROCHEMISTRY INTERNATIONAL 1872-9754 54: 452-457
Rubini, P; Milosevic, J; Engelhardt, J; Al-Khrasani, M; Franke, H; Heinrich, A; Sperlagh, B; Schwarz, SC; Schwarz, J; Norenberg, W; Illes, P
(2009)
Increase of intracellular ca2+ by adenine and uracil nucleotides in human midbrain-derived neuronal progenitor cells
CELL CALCIUM 45: 485-498
Valverde, O; Celerier, E; Baranyi, M; Vanderhaeghen, P; Maldonado, R; Sperlagh, B; Vassart, G; Ledent, C
(2009)
Gpr3 receptor, a novel actor in the emotional-like responses
PLOS ONE 1932-6203 4:
Milius, D; Sperlagh, B; Illes, P
(2008)
Up-regulation of P2X(7) receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons
NEUROSCIENCE LETTERS 1872-7972 446: 45-50